Viewing Study NCT04836858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-05-22 @ 6:07 AM
Study NCT ID: NCT04836858
Status: COMPLETED
Last Update Posted: 2024-06-20
First Post: 2021-03-24
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic Dermatitis View
None Safety View
None Efficacy View
None Atopic Eczema View
None Eczema View
None CMK389 View